DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Vamorolone
Vamorolone
Santhera Announces Publication of Long-Term Clinical Data with Vamorolone in Patients with Duchenne Muscular Dystrophy
Disruption of a Key Ligand-H-Bond Network Drives Dissociative Properties in Vamorolone for Duchenne Muscular Dystrophy Treatment
Stembook 2018.Pdf
Statistical Analysis Plan
Delta 9,11 Steroids
The Corticosteroid Compounds Prednisolone and Vamorolone Do
Rxoutlook® 3Rd Quarter 2020
Vamorolone Targets Dual Nuclear Receptors to Treat Inflammation and Dystrophic Cardiomyopathy
High Potential Disruption Report May 2020
PDCO Agenda of the 26-29 January 2021 Meeting
Medrol Dose Pack Instructions for Copd
Rxoutlook® 3Rd Quarter 2021
Mineralocorticoid Receptor
Phase 1 Trial of Vamorolone, a First-In-Class Steroid, Shows Improvements in Side Effects Via Biomarkers Bridged to Clinical
Santhera Implements Reorganization and Secures Financing to Advance Vamorolone to Pivotal Read-Out in Duchenne Muscular Dystrophy
Vamorolone Trial in Duchenne Muscular Dystrophy Shows Dose-Related Improvement of Muscle Function
The Effect of Environmental Stress and Selective Glucocorticoid Receptor Modulators on Chicken and Human Leukaemia Cells
Annexes to the Annual Report of the European Medicines Agency 2018
Top View
Inflammatory Cytokine Expression in Glioma Cells and Increases Activity and Survival in a Murine Model of Cortical Tumor
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys
Drug Repurposing Compound Library Plus (96-Well)
Wednesday, December 11, 2019 4:00Pm
2020 Medicines in Development for Children
Glucocorticoid Receptor
The Corticosteroid Compounds Prednisolone and Vamorolone Do Not Alter the Nociception Phenotype and Exacerbate Liver Injury in Sickle Cell Mice
Anti-Aging Compound Library (96-Well)
Vamorolone: a Novel Side Effect-Mitigating Steroid for the Treatment of DMD
2018 Medicines in Development for Neurological Disorders a Report on Disorders of the Brain, Spinal Cord and Nerves
Version 5 Dated 22-Mar-2019 Page 1 of 18 RESEARCH SUBJECT
Drug Repurposing Compound Library (96-Well)
Standard of Care Versus New-Wave Corticosteroids in the Treatment of Duchenne Muscular Dystrophy
Theory: Treatments for Prolonged ICU Patients May Provide New Therapeutic Avenues for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
FY 2019 Annual Report
Disruption of a Key Ligand-H-Bond Network Drives Dissociative Properties in Vamorolone for Duchenne Muscular Dystrophy Treatment
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri